Patents by Inventor Joseph Sliman

Joseph Sliman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
    Publication number: 20240082370
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 14, 2024
    Inventor: Joseph Sliman
  • Safe and effective beta-lactamase dosing for microbiome protection
    Patent number: 11872268
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: January 16, 2024
    Assignee: Theriva Biologics, Inc.
    Inventor: Joseph Sliman
  • SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
    Publication number: 20220125895
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Application
    Filed: January 10, 2022
    Publication date: April 28, 2022
    Inventor: Joseph Sliman
  • Safe and effective beta-lactamase dosing for microbiome protection
    Patent number: 11253577
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: February 22, 2022
    Assignee: Synthetic Biologics, Inc.
    Inventor: Joseph Sliman
  • SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
    Publication number: 20200297824
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Application
    Filed: June 4, 2020
    Publication date: September 24, 2020
    Inventor: Joseph Sliman
  • Safe and effective beta-lactamase dosing for microbiome protection
    Patent number: 10709773
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: July 14, 2020
    Assignee: Synthetic Biologics, Inc.
    Inventor: Joseph Sliman
  • SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
    Publication number: 20160256533
    Abstract: The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 8, 2016
    Inventor: Joseph Sliman